Literature DB >> 15666838

Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells.

Monika Ehrhart-Bornstein1, Karen Arakelyan, Alexander W Krug, Werner A Scherbaum, Stefan R Bornstein.   

Abstract

Obesity has become an epidemic problem in Western societies contributing to several disease processes including metabolic diseases, hypertension, and cardiovascular disease. Overweight and obesity are frequently associated with increased plasma levels of aldosterone suggesting a direct link between obesity hypertension and increased mineralocorticoid levels. The adipocyte has long been suggested to be directly involved in the regulation of the body's homeostasis and recent evidence now proves that human fat is a highly active endocrine tissue. We therefore tested the hypothesis that adipocyte secretory products directly stimulate adrenocortical aldosterone secretion. Indeed, secretory products from isolated human adipocytes strongly stimulated steroidogenesis in human adrenocortical cells (NCI-H295R), as well as in bovine adrenocortical cells with a predominant effect on mineralocorticoid secretion. In conclusion, a possible direct link exists between fat tissue metabolism and adrenal mineralocorticoid secretion that may be responsible for obesity-related hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15666838     DOI: 10.1081/erc-200044122

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  25 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Monozygotic twins discordant for primary aldosteronism: a case report.

Authors:  Y Kobayashi; K Yatsu; K Nakata-Shimokihara; N Inoue; T Fujikawa; N Hirawa; S Umemura; F Satoh; G P Rossi; K Tamura
Journal:  J Hum Hypertens       Date:  2017-05-25       Impact factor: 3.012

Review 3.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

4.  Adipokines: another link between obesity and hypertension.

Authors:  A R Sabbatini; A P C de Faria; R Modolo; H Moreno
Journal:  J Hum Hypertens       Date:  2014-04-17       Impact factor: 3.012

Review 5.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 6.  Obesity in kidney disease: A heavyweight opponent.

Authors:  Raphael Jose Ferreira Felizardo; Marina Burgos da Silva; Cristhiane Favero Aguiar; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2014-08-06

7.  Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism.

Authors:  Helge Müller-Fielitz; Margot Lau; Olaf Jöhren; Florian Stellmacher; Markus Schwaninger; Walter Raasch
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

8.  Deregulation of adipokines related to target organ damage on resistant hypertension.

Authors:  A R Sabbatini; A P Faria; N R Barbaro; W M Gordo; R G P Modolo; C Pinho; V Fontana; H Moreno
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

Review 9.  The ubiquitous mineralocorticoid receptor: clinical implications.

Authors:  Urseline A Hawkins; Elise P Gomez-Sanchez; Clara M Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

10.  Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients.

Authors:  Juergen Graessler; Dominik Schwudke; Peter E H Schwarz; Ronny Herzog; Andrej Shevchenko; Stefan R Bornstein
Journal:  PLoS One       Date:  2009-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.